Research ArticleClinical Studies
Expanding Sorafenib Treatment for Hepatocellular Carcinoma Beyond Barcelona Clinic Liver Cancer Stage C Patients: A National Study
CHING-TSO CHEN, CHIH-HUNG HSU, ANN-LII CHENG and YU-YUN SHAO
Anticancer Research September 2022, 42 (9) 4461-4470; DOI: https://doi.org/10.21873/anticanres.15946
CHING-TSO CHEN
1Department of Oncology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan, R.O.C.;
2Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, R.O.C.;
CHIH-HUNG HSU
2Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, R.O.C.;
3Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan, R.O.C.;
ANN-LII CHENG
2Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, R.O.C.;
3Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan, R.O.C.;
4Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, R.O.C.;
5Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan, R.O.C.
YU-YUN SHAO
2Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, R.O.C.;
3Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan, R.O.C.;
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Expanding Sorafenib Treatment for Hepatocellular Carcinoma Beyond Barcelona Clinic Liver Cancer Stage C Patients: A National Study
CHING-TSO CHEN, CHIH-HUNG HSU, ANN-LII CHENG, YU-YUN SHAO
Anticancer Research Sep 2022, 42 (9) 4461-4470; DOI: 10.21873/anticanres.15946
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.